- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 448
What Makes a Truly Valuable AI Drug Discovery Platform?
The value in AI drug discovery platforms lies in their ability to target known, yet previously unreachable, therapeutic targets. Gain Therapeutics’ Magellan™ exemplifies this by combining AI with a physics-based approach to identify novel allosteric binding sites on disease-implicated proteins.
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 157
Gain Therapeutics is ready to share the latest R&D update on Parkinson’s Disease. This event is intended for all KOL’s, Analysts, Patient Advocates, and investors who share a common interest in neurodegenerative diseases.
“Beyond Symptomatic Treatment of #Parkinson’s Disease: Gain Therapeutics R&D Update with KOL & Analyst Insights 2024”
This R&D update event will occur Thursday, February 22nd, 2024 between 11:00 am – 12:00 pm EST.
Registration information can be found here: https://lnkd.in/erx-c4vn
Participants are encouraged to send questions to
Discussion Topics will include:
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 281
Beatriz Calvo-Flores Guzman, presented at the 20th Annual WORLDSymposium discussing preclinical data demonstrating that our clinical-stage GCase regulator provided neuroprotection & restored motor function in Parkinson’s disease models following delayed administration.
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 232
Novel Treatment for Parkinson’s Advancing Through Phase 1 Clinical Trials
- Details
- Written by: Designer SM
- Category: Perspectives
- Hits: 165
Gain Therapeutics will be attending JP Morgan HealthCare Conference Jan 8th to 11th, 2024 in San Francisco.
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 162
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 345
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 263
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 145
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 122
- Details
- Written by: Developer SM
- Category: Perspectives
- Hits: 140